This author has not written his bio yet.
But we are proud to say that Andrew Humphreys contributed 3897 entries already.
The healthcare industry is increasingly focusing on niche patient populations. However, finding hard-to-reach rare disease patients is difficult and keeping them engaged over time even more so. Could machine learning platforms that deliver personalized experiences for patients and caregivers be part of the answer?
Everyone knows the terms “machine learning” and “artificial intelligence.” Few can define them, much less explain their inestimable value to clinical trials. So, it’s not surprising that, despite their ability to minimize risk, improve safety, condense timelines, and save costs, these technology tools are not widely used by the clinical trial industry.
Naming a column the “Cutting Edge” in these times may seem presumptuous. Not too long ago, “cutting edge” meant the cusp of innovation, the tech pathway to fantastic discoveries and business success. Who wouldn’t want to be out there? Today, the cutting edge we’re facing is like something out of a horror film – a whirling relentless blade that’s lopping off established institutions with relentless energy and unprecedented speed. Workplace? What’s that? Workforce? Who are they? Economy? Who knows?
The confusion and infighting that has marred the response to the COVID-19 pandemic reduces public support for and confidence in preventive measures encouraged by public health experts. It also threatens the effectiveness, scientific integrity, and reputation of key federal health agencies, potentially inflicting long-lasting damage.
Med Ad News celebrated the leading agencies/networks and creative excellence in the healthcare communications industry on June 18 with the magazine’s first-ever virtual Manny Awards. For the 31st anniversary of the black-tie gala event, Manny Awards were presented throughout the evening to healthcare agencies and networks achieving excellence across 29 categories.
Med Ad News spoke to the managing partners of Moon Rabbit, an independent advertising and marketing agency that blends consumer and healthcare talent.
Med Ad News talked to HyperPointe CEO Ezra Ernst about the agency’s recent relaunch, the signing of a new account focused on helping the United States move forward from the COVID-19 pandemic, and other topics.
Ezra T. Ernst, the recently named CEO of HyperPointe, began his tenure with a pair of major moves. Just weeks after taking the helm of the 30-year-old firm, he announced an agency relaunch and the signing of a new account focused on helping the United States move forward from the COVID-19 pandemic.
As part of a continuing growth strategy, BW Health Group – a family of interconnected companies dedicated to supporting and building partnerships with the life sciences industry – appointed Will Reese as president of Benchworks. A full-service healthcare marketing agency, Benchworks assists brands throughout the commercialization process.
Industry-renowned brand builder Jodi Brichan joined Greater Than One (GTO), a New York-based integrated full-service health and wellness marketing agency, as chief growth officer. GTO executives say the appointment is designed to build on the agency’s growth momentum and help expand the agency’s offerings while diversifying its client base.
